Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Obstetrics/Gynecology (Women’s Health) | Family Medicine

Breast Cancer Clinical Trials

A listing of Breast Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Last 

Alabama

Research Site
Birmingham Alabama

Announcing a medical research study for advanced hereditary breast cancer.

University of Alabama at Birmingham
Birmingham Alabama 35294

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

Alabama Oncology
Birmingham Alabama 35211

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

Southern Cancer Center
Mobile Alabama 36608

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

View More ▼

Bessemer Alabama 35022

Patients are needed to participate in a clinical research study evaluating NeuVax vaccine and Leukine (sargramostim, GM-CSF) and water for injection for the treatment of HER2 Negative Breast Cancer

UPDATED

Birmingham Alabama 35249

A clinical research study of pertuzumab, trastuzumab, Aromatase Inhibitor and Induction Chemotherapy for the treatment of Breast Cancer

Birmingham Alabama 35294

A clinical research study of Trastuzumab, pertuzumab and lapatinib for the treatment of Breast Neoplasms

Birmingham Alabama 35294-0006

A clinical trial seeking patients for a research study for the treatment of Breast Cancer

Birmingham Alabama 35249-3300

A clinical trial to evaluate treatments for patients with Metastatic Breast Cancer

UPDATED

Birmingham Alabama 35211

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Birmingham Alabama 35294

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Birmingham Alabama 35205

A clinical trial to evaluate treatments using Ointment and 0.1% Uracil Ointment for patients with Palmar-Plantar Erythrodysesthesia or Breast Cancer

Birmingham Alabama 35294

A Phase 2 clinical study for patients with HER-2 Positive Breast Cancer

Birmingham Alabama 35294-3300

Patients are needed to participate in a clinical research study of SGN-LIV1A to evaluate Breast Cancer

Birmingham Alabama 35205

Patients are needed to participate in a clinical research study to evaluate Breast Cancer

Mobile Alabama 36688

A clinical trial seeking patients for a research study for the treatment of Breast Cancer

UPDATED

Mobile Alabama 36604

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

UPDATED

Mobile Alabama 36608

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Mobile Alabama 36688

Patients are needed to participate in a clinical research study of Fulvestrant, BKM120 and BKM120 matching placebo to evaluate Metastatic Breast Cancer HR+, HER2-

Mobile Alabama 36604

Patients are needed to participate in a clinical research study to evaluate Breast Cancer

Muscle Shoals Alabama 35661

A clinical trial to evaluate treatments using Naproxen and Loratadine for patients with Bone Pain in Stage I - III Breast Cancer

Alaska

UPDATED

Anchorage Alaska 99508

A clinical research study of trastuzumab emtansine and trastuzumab for the treatment of Breast Cancer

Arizona

Research Site
Gilbert Arizona

Announcing a medical research study for advanced hereditary breast cancer.

Arizona Center for Cancer Care
Glendale Arizona 85306

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

Research Site
Phoenix Arizona

A Phase III Trial of Niraparib (a PARP inhibitor) Versus Physician's Choice in Her2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients (BRAVO)

Arizona Cancer Research Alliance
Scottsdale Arizona 85251

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

Research Site
Tucson Arizona

A Phase III Trial of Niraparib (a PARP inhibitor) Versus Physician's Choice in Her2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients (BRAVO)

Arizona Cancer Center
Tucson Arizona 85724

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

Yuma Regional Cancer Center
Yuma Arizona 85364

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

View More ▼

UPDATED

Chandler Arizona 85224

A clinical research study of pertuzumab, trastuzumab, Aromatase Inhibitor and Induction Chemotherapy for the treatment of Breast Cancer

Chandler Arizona 85224

A Phase 2 clinical study for patients with Metastatic Breast Cancer

Chandler Arizona 85224

Patients are needed to participate in a clinical research study evaluating Paclitaxel, BKM120 matching placebo and BKM120 for the treatment of Breast Cancer

Chandler Arizona 85224

Patients are needed to participate in a clinical research study of Fulvestrant, BKM120 and BKM120 matching placebo to evaluate Metastatic Breast Cancer HR+, HER2-

Gilbert Arizona 85234

A clinical trial to evaluate treatments for patients with Metastatic Breast Cancer

Glendale Arizona 85306

A clinical study for patients with Breast Cancer

Glendale Arizona 85301

A clinical research study for the treatment of Breast Cancer or HER2 Positive Breast Cancer

UPDATED

Glendale Arizona 85306

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Glendale Arizona 83506

A Phase 2/Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2, Carboplatin AUC 2 and gemcitabine 1000 mg

Goodyear Arizona 85338

A clinical trial seeking patients for a research study for the treatment of Breast Cancer

UPDATED

Goodyear Arizona 85338

A clinical trial to evaluate treatments using BMN 673 for patients with Breast Neoplasms, BRCA 1 Gene Mutation or BRCA 2 Gene Mutation

UPDATED

Mesa Arizona 85206

A clinical trial to evaluate treatments using RTA 408 Lotion for patients with Breast Cancer

Mesa Arizona 85206

A Phase 2/Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2, Carboplatin AUC 2 and gemcitabine 1000 mg

Phoenix Arizona 85013

A clinical study for patients with Breast Cancer

UPDATED

Phoenix Arizona 85013

A clinical trial to evaluate treatments using RTA 408 Lotion for patients with Breast Cancer

Phoenix Arizona

Patients are needed to participate in a clinical research study evaluating Paclitaxel, BKM120 matching placebo and BKM120 for the treatment of Breast Cancer

Scottsdale Arizona 85251

A clinical study for patients with Breast Cancer

Scottsdale Arizona 85258

A clinical trial seeking patients for a research study of Veliparib (ABT-888) and Placebo

UPDATED

Scottsdale Arizona 85258

A clinical trial to evaluate treatments using BMN 673 and Physician's-Choice for patients with Breast Neoplasms, BRCA 1 Gene Mutation or BRCA 2 Gene Mutation

UPDATED

Scottsdale Arizona 85251

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Scottsdale Arizona 85258

A clinical trial to evaluate treatments using FFDM Mammography and DBT Mammography for patients with Breast Cancer

First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.